Novo Holdings is a prominent healthcare and life sciences investor, managing assets for the Novo Nordisk Foundation. Based in Copenhagen, with additional offices globally, the company focuses on creating sustainable value across healthcare and life sciences sectors, including being the controlling shareholder in Novo Nordisk A/S and Novozymes A/S.
- Healthcare
- Pharmaceuticals
- Biotechnology
- Marketing
- Analytics
- Clinical Research
- Contract Research Organization (Cro)
- Drug Development
- Preclinical Safety Testing
- Bioanalysis
Leadership
| Name | Title | ||
|---|---|---|---|
| Morten Beck Jørgensen | Managing Partner |
in/morten-beck-j%C3%B8rgensen-9630011
|
|
| Senior Partner |
|
|
|
| Senior Partner |
|
|
|
| Senior Partner |
|
|
|
| CFO |
|
|
Recent Transactions involving Novo Holdings
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Novo Holdings to acquire majority stake in Stingray Marine Solutions, a leading provider of aquaculture technology |
Stingray Marine Solutions |
Novo Holdings |
Aquaculture Technology | |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →